Osteopontin attenuates acute gastrointestinal graft-versus-host disease by preventing apoptosis of intestinal epithelial cells

Biochemical and Biophysical Research Communications

Volumn 485, Issue 2, 2017, Pages 468-475

  Kawakami, Kentaro ^a   Minami, Naoki ^b   Matsuura, Minoru ^b   Iida, Tomoya ^a   Toyonaga, Takahiko ^c   Nagaishi, Kanna ^a   Arimura, Yoshiaki ^a   Fujimiya, Mineko ^a   Uede, Toshimitsu ^d   Nakase, Hiroshi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KITASATO INSTITUTE HOSPITAL   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Graft versus host disease (GVHD); Osteopontin

Indexed keywords

FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 18; OSTEOPONTIN; TUMOR NECROSIS FACTOR; CYTOKINE;

ACUTE GRAFT VERSUS HOST DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GASTROINTESTINAL GRAFT VERSUS HOST DISEASE; GENE EXPRESSION; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; SPLEEN CELL; ACUTE DISEASE; ADVERSE EFFECTS; ALLOGRAFT; ANIMAL; BONE MARROW TRANSPLANTATION; C57BL MOUSE; DBA MOUSE; EPITHELIUM CELL; FLUORESCENCE MICROSCOPY; GASTROINTESTINAL DISEASE; GENETICS; GRAFT VS HOST DISEASE; IMMUNOLOGY; INTESTINE MUCOSA; KNOCKOUT MOUSE; LYMPHOCYTE COUNT; METABOLISM; PATHOLOGY; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX;

ACUTE DISEASE; ALLOGRAFTS; ANIMALS; APOPTOSIS; BONE MARROW TRANSPLANTATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; EPITHELIAL CELLS; FAS LIGAND PROTEIN; FLOW CYTOMETRY; GASTROINTESTINAL DISEASES; GENE EXPRESSION; GRAFT VS HOST DISEASE; INTESTINAL MUCOSA; LYMPHOCYTE COUNT; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE; OSTEOPONTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX;

EID: 85013485360     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2017.02.047     Document Type: Article

References (22)

1. [1] Copelan, E.A., Hematopoietic stem-cell transplantation. N. Engl. J. Med. 354 (2006), 1813–1826.
2. [2] Ferrara, J.L., Levine, J.E., Reddy, P., et al. Graft-versus-host disease. Lancet 373 (2009), 1550–1561.
3. [3] Markey, K.A., MacDonald, K.P., Hill, G.R., The biology of graft-versus-host disease: experimental systems instructing clinical practice. Blood 124 (2014), 354–362.
4. [4] Oldberg, A., Franzén, A., Heinegard, D., Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc. Natl. Acad. Sci. U. S. A. 83 (1986), 8819–8823.
5. [5] Shevde, L.A., Samant, R.S., Role of osteopontin in the pathophysiology of cancer. Matrix Biol. 37 (2014), 131–141.
6. [6] Denhardt, D.T., Noda, M., O'Regan, A.W., et al. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J. Clin. Invest. 107 (2001), 1055–1061.
7. [7] Brown, L.F., Berse, B., Van de Water, L., et al. Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol. Biol. Cell 3 (1992), 1169–1180.
8. [8] Ashkar, S., Weber, G.F., Panoutsakopoulou, V., et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287 (2000), 860–864.
9. [9] Zhang, H., Guo, M., Chen, J.H., et al. Osteopontin knockdown inhibits αv, β3 integrin-induced cell migration and invasion and promotes apoptosis of breast cancer cells by inducing autophagy and inactivating the PI3K/Akt/mTOR pathway. Cell Physiol. Biochem. 33 (2014), 991–1002.
10. [10] Morales-Ibanez, O., Domínguez, M., Ki, S.H., et al. Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis. Hepatology 58 (2013), 1742–1756.
11. [11] Sato, T., Nakai, T., Tamura, N., et al. Osteopontin/Eta-1 upregulated in crohn's disease regulates the Th1 immune response. Gut 54 (2005), 1254–1262.
12. [12] Komine-Aizawa, S., Masuda, H., Mazaki, T., et al. Plasma osteopontin predicts inflammatory bowel disease activities. Int. Surg. 100 (2015), 38–43.
13. [13] Zhao, F., Zhang, Y., Wang, H., et al. Blockade of osteopontin reduces alloreactive CD8+T cell-mediated graft-versus-host disease. Blood 117 (2011), 1723–1733.
14. [14] Cooke, K.R., Kobzik, L., Martin, T.R., et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood 88 (1996), 3230–3239.
15. [15] Hill, G.R., Cooke, K.R., Teshima, T., et al. Interleukin-11 promotes T cell polarization and prevents acute graft versus-host disease after allogeneic bone marrow transplantation. J. Clin. Invest. 102 (1998), 115–123.
16. [16] Weigmann, B., Tubbe, I., Seidel, D., et al. Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nat. Protoc. 2 (2007), 2307–2311.
17. [17] Rittling, S.R., Singh, R., Osteopontin in immune-mediated diseases. J. Dent. Res. 94 (2015), 1638–1645.
18. [18] Heilmann, K., Hoffmann, U., Witte, E., et al. Osteopontin as two-sided mediator of intestinal inflammation. J. Cell Mol. Med. 13 (2009), 1162–1174.
19. [19] Toyonaga, T., Nakase, H., Ueno, S., et al. Osteopontin deficiency accelerates spontaneous colitis in mice with disrupted gut microbiota and macrophage phagocytic activity. PLoS One(8), 2015 Aug 14, 10 e0135552.
20. [20] Dupaul-Chicoine, J., Yertssian, G., Doiron, K., et al. Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity 32 (2010), 367–378.
21. [21] Okamoto, I., Kohno, K., Tanimoto, T., et al. IL-18 prevents the development of chronic graft-versus-host disease in mice. J. Immunol. 164 (2000), 6067–6074.
22. [22] Diao, H., Iwabuchi, K., Li, L., et al. Osteopontin regulates development and function of invariant natural killer T cells. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 15884–15889.